Novartis AG (NVSEF)
150.12
+0.31
(+0.21%)
USD |
OTCM |
Oct 26, 16:00
Novartis Price : 150.12 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 148.65 | 150.12 | 148.65 | 150.12 | 799.00 |
| Oct 23, 2026 | 157.60 | 157.60 | 149.81 | 149.81 | 140449.0 |
| Oct 22, 2026 | 146.18 | 146.18 | 146.18 | 146.18 | 73.00 |
| Oct 21, 2026 | 146.24 | 146.34 | 146.18 | 146.18 | 2904.00 |
| Oct 20, 2026 | 146.46 | 146.46 | 146.46 | 146.46 | 89.00 |
| Oct 19, 2026 | 153.25 | 153.36 | 146.46 | 146.46 | 863.00 |
| Oct 16, 2026 | 153.90 | 153.90 | 143.90 | 143.90 | 1212.00 |
| Oct 15, 2026 | 153.92 | 153.92 | 144.32 | 144.32 | 234755.0 |
| Oct 14, 2026 | 137.80 | 137.80 | 137.80 | 137.80 | 149.00 |
| Oct 13, 2026 | 140.73 | 140.73 | 137.80 | 137.80 | 854.00 |
| Oct 12, 2026 | 143.18 | 143.18 | 143.18 | 143.18 | 351.00 |
| Oct 09, 2026 | 146.23 | 146.23 | 139.98 | 139.98 | 581.00 |
| Oct 08, 2026 | 141.94 | 141.94 | 135.75 | 135.75 | 414.00 |
| Oct 07, 2026 | 134.22 | 134.22 | 134.22 | 134.22 | 301.00 |
| Oct 06, 2026 | 140.60 | 140.60 | 134.22 | 134.22 | 164548.0 |
| Oct 05, 2026 | 136.39 | 136.39 | 134.53 | 134.53 | 1242.00 |
| Oct 02, 2026 | 134.20 | 137.40 | 134.20 | 134.20 | 633.00 |
| Oct 01, 2026 | 140.93 | 140.93 | 140.93 | 140.93 | 66148.00 |
| Sep 30, 2026 | 140.93 | 140.93 | 140.93 | 140.93 | 303471.0 |
| Sep 29, 2026 | 139.02 | 144.94 | 139.02 | 144.94 | 100304.0 |
| Sep 28, 2026 | 142.68 | 146.00 | 139.41 | 146.00 | 5925.00 |
| Sep 25, 2026 | 140.96 | 140.96 | 140.96 | 140.96 | 312.00 |
| Sep 24, 2026 | 138.10 | 142.51 | 138.10 | 142.51 | 557.00 |
| Sep 23, 2026 | 138.38 | 138.38 | 138.38 | 138.38 | 213.00 |
| Sep 22, 2026 | 138.38 | 138.38 | 138.38 | 138.38 | 36792.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 59.98 |
| Addex Therapeutics Ltd. | 2.90 |
| Oculis Holding AG | 7.96 |
| Sandoz Group AG | 99.68 |
| Galderma Group AG | 46.15 |
Price Related Metrics
| PE Ratio | 22.66 |
| PS Ratio | 5.276 |
| Price to Book Value | 6.615 |
| Price to Free Cash Flow | 19.04 |
| Earnings Yield | 4.41% |
| Market Cap | 274.80B |
| Operating PE Ratio | 17.84 |
| Normalized PE Ratio | 21.11 |